Your browser doesn't support javascript.
loading
A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence.
Golding, Nick; Price, David J; Ryan, Gerard; McVernon, Jodie; McCaw, James M; Shearer, Freya M.
Afiliación
  • Golding N; Telethon Kids Institute, Nedlands, Australia.
  • Price DJ; Curtin University, Perth, Australia.
  • Ryan G; Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital and The University of Melbourne, Victoria, Australia.
  • McVernon J; Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
  • McCaw JM; Telethon Kids Institute, Nedlands, Australia.
  • Shearer FM; Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Elife ; 122023 01 20.
Article en En | MEDLINE | ID: mdl-36661303
Against a backdrop of widespread global transmission, a number of countries have successfully brought large outbreaks of COVID-19 under control and maintained near-elimination status. A key element of epidemic response is the tracking of disease transmissibility in near real-time. During major outbreaks, the effective reproduction number can be estimated from a time-series of case, hospitalisation or death counts. In low or zero incidence settings, knowing the potential for the virus to spread is a response priority. Absence of case data means that this potential cannot be estimated directly. We present a semi-mechanistic modelling framework that draws on time-series of both behavioural data and case data (when disease activity is present) to estimate the transmissibility of SARS-CoV-2 from periods of high to low - or zero - case incidence, with a coherent transition in interpretation across the changing epidemiological situations. Of note, during periods of epidemic activity, our analysis recovers the effective reproduction number, while during periods of low - or zero - case incidence, it provides an estimate of transmission risk. This enables tracking and planning of progress towards the control of large outbreaks, maintenance of virus suppression, and monitoring the risk posed by re-introduction of the virus. We demonstrate the value of our methods by reporting on their use throughout 2020 in Australia, where they have become a central component of the national COVID-19 response.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 1_surtos_doencas_emergencias / 2_cobertura_universal / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Epidemias / COVID-19 Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 1_surtos_doencas_emergencias / 2_cobertura_universal / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Epidemias / COVID-19 Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Australia
...